Comparison of disk diffusion agar method and E-test for determination of sensitivity and resistance of Klebsiella and Acinetobacter strains to Cefepime in patients with ventilator-associated pneumonia in intensive care unit


Intensive Care Unit

How to Cite

Falahatian, M. (2019). Comparison of disk diffusion agar method and E-test for determination of sensitivity and resistance of Klebsiella and Acinetobacter strains to Cefepime in patients with ventilator-associated pneumonia in intensive care unit. Internal Medicine and Medical Investigation Journal, 4(1).


Background: Ventilator-associated pneumonia (VAP) is one of the common causes of death in intensive care unit (ICU), and microorganisms such as Acinetobacter and Klebsiella are the main contributing factors. The aim of this study was to compare disk diffusion agar method with E-test for determination of sensitivity of Klebsiella and Acinetobacter strains isolated from pulmonary sputum of patients with VAP in ICU to Cefepime antibiotic.

Methods: In this descriptive cross-sectional study, 100 patients with VAP, that had 55 cases for Acinetobacter and 45 cases for Klebsiella as the causing microorganisms according to antibiogram, were included in the study. Sensitivity and resistance of the species to Cefepime antibiotic were assessed using two methods: disk diffusion agar and E-test.

Results: Sensitivity and specificity of disk diffusion test were respectively calculated 100 and 25%, and on the other side, positive predictive value was 87.5% and negative predictive value was 100%. According to kappa test, kappa coefficient was 0.35 (P<0.0001) which demonstrated the agreement between two tests.

Conclusion: Comparing to E-test, disk diffusion agar method had high sensitivity and low specificity for determination of resistance and sensitivity of Acinetobacter and Klebsiella microorganisms to Cefepime in patients with VAP in ICU.


1. Society AT, America IDSo. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American journal of respiratory and critical care medicine. 2005;171(4):388.
2. Kalil AC, Metersky ML, Klompas M, Muscedere J, Sweeney DA, Palmer LB, et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clinical Infectious Diseases. 2016;63(5):e61-e111.
3. Vincent J-L, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin M-H, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study. Jama. 1995;274(8):639-44.
4. Blot S, Koulenti D, Dimopoulos G, Martin C, Komnos A, Krueger WA, et al. Prevalence, risk factors, and mortality for ventilator-associated pneumonia in middle-aged, old, and very old critically ill patients. Critical care medicine. 2014;42(3):601-9.
5. Chastre J, Fagon J-Y. Ventilator-associated pneumonia. American journal of respiratory and critical care medicine. 2002;165(7):867-903.
6. Hunter JD. Ventilator associated pneumonia. Bmj. 2012;344(e3325):e3225.
7. Afshari A, Pagani L, Harbarth S. Year in review 2011: Critical Care–infection. Critical Care. 2012;16(6):242.
8. Kalanuria AA, Zai W, Mirski M. Ventilator-associated pneumonia in the ICU. Critical care. 2014;18(2):208.
9. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest. 2002;122(6):2115-21.
10. Weiss E, Essaied W, Adrie C, Zahar J-R, Timsit J-F. Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials. Critical Care. 2017;21(1):162.
11. Peleg AY, Hooper DC. Hospital-acquired infections due to gram-negative bacteria. New England Journal of Medicine. 2010;362(19):1804-13.
12. Clerc O, Prod'hom G, Vogne C, Bizzini A, Calandra T, Greub G. Impact of matrix-assisted laser desorption ionization time-of-flight mass spectrometry on the clinical management of patients with Gram-negative bacteremia: a prospective observational study. Clinical infectious diseases. 2012;56(8):1101-7.
13. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. Journal of pharmaceutical analysis. 2016;6(2):71-9.
14. Reller LB, Weinstein M, Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: a review of general principles and contemporary practices. Clinical infectious diseases. 2009;49(11):1749-55.
15. Erfani Y, Safdari R, Chobineh H, Mirsalehian A, Rasti A, Einollahi N, et al. Comparison of E. test and Disk Diffusion Agar in Detection of Antibiotic Susceptibility of E. coli Isolated from Patients with Urinary Tract Infection in Tehran Shariati Hospital. Scientific Journal of Hamadan University of Medical Sciences. 2008;15(2):27-31.
16. Jorgensen JH, Turnidge JD. Susceptibility test methods: dilution and disk diffusion methods. Manual of Clinical Microbiology, Eleventh Edition: American Society of Microbiology; 2015. p. 1253-73.
17. Ogata SK, Gales AC, Kawakami E. Antimicrobial susceptibility testing for Helicobacter pylori isolates from Brazilian children and adolescents: comparing agar dilution, E-test, and disk diffusion. Brazilian Journal of Microbiology. 2014;45(4):1439-48.
18. Pennekamp A, Pünter V, Zbinden R. Disk diffusion, agar dilution and the E-test for susceptibility testing of Corynebacterium jeikeium. Clinical Microbiology and Infection. 1996;2(3):209-13.
19. Lo-Ten-Foe JR, de Smet AMG, Diederen BM, Kluytmans JA, van Keulen PH. Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains. Antimicrobial agents and chemotherapy. 2007;51(10):3726-30.
20. Maalej S, Meziou M, Rhimi F, Hammami A. Comparison of disc diffusion, Etest and agar dilution for susceptibility testing of colistin against Enterobacteriaceae. Letters in applied microbiology. 2011;53(5):546-51.
21. Rechenchoski DZ, Dambrozio AML, Vivan ACP, Schuroff PA, das Neves Burgos T, Pelisson M, et al. Antimicrobial activity evaluation and comparison of methods of susceptibility for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacter spp. isolates. brazilian journal of microbiology. 2017;48(3):509-14.
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.